$GRHI
GOLD ROCK HOLDINGS, INC.

2024 Q3 Form 10-Q Financial Statement

#000109181824000080 Filed on August 02, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q4
Revenue $66.00K $6.500K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit $66.00K $6.500K
YoY Change
Gross Profit Margin 100.0% 100.0%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $45.60K $99.50K
YoY Change 332.02% 866.2%
Operating Profit $20.41K -$93.00K
YoY Change -293.34% 803.08%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings $20.41K -$93.00K
YoY Change -293.34% 803.08%
Net Earnings / Revenue 30.92% -1430.75%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 236.9M shares 236.9M shares 231.1M shares
Diluted Shares Outstanding 238.1M shares 238.1M shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $215.3K $234.6K $108.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $44.00K $6.500K
Other Receivables
Total Short-Term Assets $259.3K $241.1K $108.00
YoY Change 166119.87% 20197.47% -91.59%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $259.3K $241.1K $108.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $259.3K $241.1K $108.00
YoY Change 166119.87% 20197.47% -91.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $81.59K $83.82K $9.900K
YoY Change 1010.0% 1584.84% -97.54%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $81.59K $83.82K $9.900K
Total Long-Term Liabilities
Total Liabilities $81.59K $83.82K $9.900K
YoY Change 1010.0% 1584.84% -97.54%
SHAREHOLDERS EQUITY
Retained Earnings -$1.104M -$1.125M -$866.0K
YoY Change 29.77% 33.82% 36.66%
Common Stock $238.1K $238.1K $231.1K
YoY Change 3.07% 3.07% 164.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $177.7K $157.3K -$9.792K
YoY Change
Total Liabilities & Shareholders Equity $259.3K $241.1K $108.00
YoY Change 166119.87% 20197.47% -91.59%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q4
OPERATING ACTIVITIES
Net Income $20.41K -$93.00K
YoY Change -293.34% 803.08%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Local Phone Number
LocalPhoneNumber
306-6090
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2023Q4 grhi Accrued Board Of Director Compensation
AccruedBoardOfDirectorCompensation
usd
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
236886969 shares
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
108 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6500 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
108 usd
CY2023Q4 us-gaap Assets
Assets
108 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
9900 usd
CY2024Q2 grhi Accrued Board Of Director Compensation
AccruedBoardOfDirectorCompensation
80500 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9900 usd
CY2023Q4 us-gaap Liabilities
Liabilities
9900 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
850000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
850000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
231053636 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
231053636 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
238136 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
231053 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-9792 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
350000 usd
CY2024Q1 grhi Capital Contributions Director
CapitalContributionsDirector
700 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-165596 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
175312 usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
75000 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-92999 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
157313 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_846_eus-gaap--UseOfEstimates_zkFLlESs81Ob" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86D_zgnzCizGCO7b">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of condensed consolidated financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1124632 usd
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
700 usd
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
30760 usd
grhi Common Stock Issued To Prepay Director For Payments Of Operating Expenses
CommonStockIssuedToPrepayDirectorForPaymentsOfOperatingExpenses
29000 usd
grhi Stock Issuance To Reimburse
StockIssuanceToReimburse
0.0042
grhi Agreement Monthly Charges
AgreementMonthlyCharges
1000 usd
us-gaap Other Expenses
OtherExpenses
3000 usd
us-gaap Other Expenses
OtherExpenses
6000 usd
CY2024Q2 grhi Agreement Amount Payable
AgreementAmountPayable
95000 usd
CY2024Q2 grhi Annually Paid
AnnuallyPaid
75000 usd
CY2024Q2 grhi Board Of Director Compensation
BoardOfDirectorCompensation
0 usd
CY2023Q2 grhi Board Of Director Compensation
BoardOfDirectorCompensation
0 usd
grhi Board Of Director Compensation
BoardOfDirectorCompensation
75000 usd
grhi Board Of Director Compensation
BoardOfDirectorCompensation
170000 usd
us-gaap Related Party Transaction Description Of Transaction
RelatedPartyTransactionDescriptionOfTransaction
The Company entered into an agreement with the officer of LOOT8 for $12,500 monthly of which $10,000 will be paid monthly and $2,500 will be deferred until the Company’s financial health is projected to support full payment.
CY2024Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
37500 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
62500 usd
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
850000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
850000000 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
238136969 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
238136969 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
231053636 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
231053636 shares
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
40952381 usd
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
172000 shares
grhi Common Stock Issued For Consulting And Director Compensation Shares
CommonStockIssuedForConsultingAndDirectorCompensationShares
6904761 shares
grhi Common Stock Issued For Consulting And Director Compensation
CommonStockIssuedForConsultingAndDirectorCompensation
29000 usd
us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
7083333 shares
us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
425000 usd
CY2024Q1 grhi Sponsorship Description
SponsorshipDescription
Company’s wholly owned subsidiary entered into a sponsorship commitment with a consultant to the University of Houston in the amount of $125,000 for one year ending on February 12, 2025 to be paid in twelve (12) installments of $10,416.66 each.
CY2024Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
20821 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
41649 usd

Files In Submission

Name View Source Status
0001091818-24-000080-index-headers.html Edgar Link pending
0001091818-24-000080-index.html Edgar Link pending
0001091818-24-000080.txt Edgar Link pending
0001091818-24-000080-xbrl.zip Edgar Link pending
ex311.htm Edgar Link pending
ex312.htm Edgar Link pending
ex321.htm Edgar Link pending
ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
grhi-20240630.xsd Edgar Link pending
grhi20240630.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
grhi-20240630_cal.xml Edgar Link unprocessable
grhi-20240630_def.xml Edgar Link unprocessable
grhi-20240630_pre.xml Edgar Link unprocessable
grhi20240630_htm.xml Edgar Link completed
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
grhi-20240630_lab.xml Edgar Link unprocessable